The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in changes in management and imaging routines for patients with hematological malignancies. Treating physicians had to familiarize themselves with a new disease, with distinct imaging manifestations, sometimes overlapping with other infections prevalent in this patient population. In some aspects, infected hematological patients might exhibit a different disease course, and routine imaging in asymptomatic hematological patients may result in unexpected COVID-19 findings, implying covert infection, that should be further explored. Furthermore, some complications of hematological diseases and treatments may present with findings similar to COVID-19 manifestations, and treating physicians must consider both possibilities in the differential diagnosis. In this review, we aimed to present the influence the COVID-19 pandemic had on hematological malignancy imaging.

1.
Weinkove
R
,
McQuilten
ZK
,
Adler
J
,
Agar
MR
,
Blyth
E
,
Cheng
AC
,
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
.
Med J Aust
.
2020 Jun
;
212
:
481
9
.
2.
Lai
AG
,
Pasea
L
,
Banerjee
A
,
Hall
G
,
Denaxas
S
,
Chang
WH
,
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study
.
BMJ Open
.
2020 Nov 17
;
10
:
e043828
.
3.
Rubin
GD
,
Ryerson
CJ
,
Haramati
LB
,
Sverzellati
N
,
Kanne
JP
,
Raoof
S
,
The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society
.
Radiology
.
2020 Jul
;
296
:
172
80
.
4.
Revzin
MV
,
Raza
S
,
Warshawsky
R
,
D’Agostino
C
,
Srivastava
NC
,
Bader
AS
,
Multisystem imaging manifestations of COVID-19, part 1: viral pathogenesis and pulmonary and vascular system complications
.
Radiographics
.
2020 Oct
;
40
:
1574
99
.
5.
Hochhegger
B
,
Zanon
M
,
Altmayer
S
,
Mandelli
NS
,
Stüker
G
,
Mohammed
TL
,
COVID-19 mimics on chest CT: a pictorial review and radiologic guide
.
Br J Radiol
.
2021 Feb 1
;
94
:
20200703
.
6.
Hanfi
SH
,
Lalani
TK
,
Saghir
A
,
McIntosh
LJ
,
Lo
HS
,
Kotecha
HM
.
COVID-19 and its mimics: what the radiologist needs to know
.
J Thorac Imaging
.
2021 Jan
;
36
(
1
):
W1
10
. .
7.
Duzgun
SA
,
Durhan
G
,
Demirkazik
FB
,
Akpinar
MG
,
Ariyurek
OM
.
COVID-19 pneumonia: the great radiological mimicker
.
Insights Imaging
.
2020 Nov 23
;
11
:
118
. .
8.
Wong
HYF
,
Lam
HYS
,
Fong
AH
,
Leung
ST
,
Chin
TW
,
Lo
CSY
,
Frequency and distribution of chest radiographic findings in COVID-19 positive patients
.
Radiology
.
2020 Aug
;
296
(
2
):
E72
8
.
9.
Wang
Y
,
Dong
C
,
Hu
Y
,
Li
C
,
Ren
Q
,
Zhang
X
,
Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a Longitudinal Study
.
Radiology
.
2020 Aug
;
296
:
E55
64
.
10.
Pan
F
,
Ye
T
,
Sun
P
,
Gui
S
,
Liang
B
,
Li
L
,
Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19)
.
Radiology
.
2020 Jun
;
295
:
715
21
.
11.
Daoussis
D
,
Leonidou
L
,
Kalogeropoulou
C
,
Paliogianni
F
,
Tzouvelekis
A
.
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed
.
Rheumatol Int
.
2021 Oct
;
41
(
10
):
1839
43
. .
12.
Riches
JC
.
Impact of COVID-19 in patients with lymphoid malignancies
.
World J Virol
.
2021 May 25
;
10
(
3
):
97
110
. .
13.
Reuken
PA
,
Stallmach
A
,
Pletz
MW
,
Brandt
C
,
Andreas
N
,
Hahnfeld
S
,
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
.
Leukemia
.
2021 Mar
;
35
:
920
3
.
14.
Yasuda
H
,
Mori
Y
,
Chiba
A
,
Bai
J
,
Murayama
G
,
Matsushita
Y
,
Resolution of one-year persisting COVID-19 pneumonia and development of immune thrombocytopenia in a follicular lymphoma patient with preceding rituximab maintenance therapy: a follow-up report and literature review of cases with prolonged infections
.
Clin Lymphoma Myeloma Leuk
.
2021 Oct
;
21
:
e810
6
.
15.
Raoufi
M
,
Kahkooei
S
,
Haseli
S
,
Robatjazi
F
,
Bahri
J
,
Khalili
N
.
Organizing pneumonia-like pattern in COVID-19
.
Adv Respir Med
.
2021 Oct 6
. Epub ahead of print.
16.
Garrana
SH
,
Som
A
,
Ndakwah
GS
,
Yeung
T
,
Febbo
J
,
Heeger
AP
,
Comparison of chest CT Findings of COVID-19, influenza, and organizing pneumonia: a Multireader Study
.
AJR Am J Roentgenol
.
2021 Nov
;
217
(
5
):
1093
102
.
17.
Cheson
BD
,
Fisher
RI
,
Barrington
SF
,
Cavalli
F
,
Schwartz
LH
,
Zucca
E
,
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification
.
J Clin Oncol
.
2014 Sep 20
;
32
:
3059
68
.
18.
Zamagni
E
,
Tacchetti
P
,
Cavo
M
.
Imaging in multiple myeloma: how? When?
Blood
.
2019 Feb 14
;
133
:
644
51
. .
19.
Katal
S
,
Azam
S
,
Bombardieri
E
,
Picchio
M
,
Gholamrezanezhad
A
.
Reopening the country: recommendations for nuclear medicine departments
.
World J Nucl Med
.
2021 Jan–Mar
;
20
(
1
):
1
6
. .
20.
Sreedharan
S
,
Mian
M
,
McArdle
DJT
,
Rhodes
A
.
The impact of the COVID-19 pandemic on diagnostic imaging services in Australia
.
J Med Imaging Radiat Oncol
.
2021 Jul 20
:
10
. Epub ahead of print.
21.
Norbash
AM
,
Moore
AV
,
Recht
MP
,
Brink
JA
,
Hess
CP
,
Won
JJ
,
Early-stage radiology volume effects and considerations with the coronavirus disease 2019 (COVID-19) pandemic: adaptations, risks, and lessons learned
.
J Am Coll Radiol
.
2020 Sep
;
17
:
1086
95
.
22.
Joob
B
,
Wiwanitkit
V
.
18F-FDG PET/CT and COVID-19
.
Eur J Nucl Med Mol Imaging
.
2020 Jun
;
47
:
1348
. .
23.
Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: an Information Statement from ASNC and SNMMI
.
J Nucl Med
.
2020 Jun
;
61
:
784
91
.
24.
Gnanasegaran
G
,
Huang
HL
,
Williams
J
,
Bomanji
J
.
Coronavirus pandemic: what nuclear medicine departments should know
.
J Nucl Med Technol
.
2020 Jun
;
48
:
89
97
. .
25.
Qin
C
,
Liu
F
,
Yen
TC
,
Lan
X
.
18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
.
Eur J Nucl Med Mol Imaging
.
2020 May
;
47
:
1281
6
. .
26.
Deng
Y
,
Lei
L
,
Chen
Y
,
Zhang
W
.
The potential added value of FDG PET/CT for COVID-19 pneumonia
.
Eur J Nucl Med Mol Imaging
.
2020 Jul
;
47
:
1634
5
. .
27.
Charters
PFP
,
Little
D
,
Rodrigues
JCL
,
Graham
RN
,
Redman
SL
.
18FDG-PET/CT findings in COVID-19: a single centre retrospective radiological review
.
BJR Case Rep
.
2020 Sep 1
;
6
:
20200091
. .
28.
Minamimoto
R
,
Hotta
M
,
Ishikane
M
,
Inagaki
T
.
FDG-PET/CT images of COVID-19: a comprehensive review
.
Glob Health Med
.
2020 Aug 31
;
2
(
4
):
221
6
. .
29.
Colandrea
M
,
Gilardi
L
,
Travaini
LL
,
Fracassi
SLV
,
Funicelli
L
,
Grana
CM
.
18F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces
.
Jpn J Radiol
.
2020 Nov
;
38
:
1007
11
. .
30.
Zou
S
,
Zhu
X
.
FDG PET/CT of COVID-19
.
Radiology
.
2020 Aug
;
296
:
E118
. .
31.
Amini
H
,
Divband
G
,
Montahaei
Z
,
Dehghani
T
,
Kaviani
H
,
Adinehpour
Z
,
A case of COVID-19 lung infection first detected by [18F]FDG PET-CT
.
Eur J Nucl Med Mol Imaging
.
2020 Jul
;
47
:
1771
2
.
32.
Kamani
CH
,
Jreige
M
,
Pappon
M
,
Fischbacher
A
,
Borens
O
,
Monney
P
,
Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever
.
Eur J Nucl Med Mol Imaging
.
2020 Jul
;
47
:
2036
7
.
33.
Xu
X
,
Yu
C
,
Qu
J
,
Zhang
L
,
Jiang
S
,
Huang
D
,
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
.
Eur J Nucl Med Mol Imaging
.
2020 May
;
47
:
1275
80
.
34.
Karimi-Galougahi
M
,
Yousefi-Koma
A
,
Bakhshayeshkaram
M
,
Raad
N
,
Haseli
S
.
18FDG PET/CT scan reveals hypoactive orbitofrontal cortex in anosmia of COVID-19
.
Acad Radiol
.
2020 Jul
;
27
:
1042
3
. .
35.
Halsey
R
,
Priftakis
D
,
Mackenzie
S
,
Wan
S
,
Davis
LM
,
Lilburn
D
,
COVID-19 in the act: incidental 18F-FDG PET/CT findings in asymptomatic patients and those with symptoms not primarily correlated with COVID-19 during the United Kingdom coronavirus lockdown
.
Eur J Nucl Med Mol Imaging
.
2021 Jan
;
48
:
269
81
.
36.
Fang
Y
,
Zhang
H
,
Xie
J
,
Lin
M
,
Ying
L
,
Pang
P
,
Sensitivity of chest CT for COVID-19: comparison to RT-PCR
.
Radiology
.
2020 Aug
;
296
:
E115
7
.
37.
Meena
JP
,
Kumar Gupta
A
,
Tanwar
P
,
Ram Jat
K
,
Mohan Pandey
R
,
Seth
R
.
Clinical presentations and outcomes of children with cancer and COVID-19: a systematic review
.
Pediatr Blood Cancer
.
2021 Jun
;
68
(
6
):
e29005
. .
38.
Karasu
S
,
Sinci
KA
,
Yildiz
Y
,
Gumus
C
,
Tosun
O
.
Chemotherapy-induced pulmonary toxicity mimicking COVID-19 pneumonia
.
Curr Med Imaging
.
2021
;
17
(
12
):
1510
12
.
39.
Dai
Y
,
Liu
S
,
Zhang
Y
,
Li
X
,
Zhao
Z
,
Liu
P
,
A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature
.
J Med Case Rep
.
2021 Feb 1
;
15
:
41
.
40.
Rossi
E
,
Schinzari
G
,
Tortora
G
.
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
.
J Immunother Cancer
.
2020 Jul
;
8
(
2
):
e000952
. .
41.
Prakash
S
,
Kumar
R
,
Vinjamuri
S
.
What role does 18F-fluorodeoxyglucose PET-computed tomography have in the current pandemic and beyond?
Nucl Med Commun
.
2021 Feb
;
42
(
2
):
113
6
. .
42.
Giannakis
A
,
Móré
D
,
Erdmann
S
,
Kintzelé
L
,
Fischer
RM
,
Vogel
MN
,
COVID-19 pneumonia and its lookalikes: how radiologists perform in differentiating atypical pneumonias
.
Eur J Radiol
.
2021 Oct 19
;
144
:
110002
.
43.
Tahtabasi
M
,
Hosbul
T
,
Karaman
E
,
Akin
Y
,
Konukoglu
O
,
Sahiner
F
.
Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis
.
Clin Imaging
.
2021 Nov
;
79
:
104
9
. .
44.
Ramanathan
M
,
Chueng
T
,
Fernandez
E
,
Gonzales-Zamora
J
.
Concomitant renal and splenic infarction as a complication of COVID-19: a case report and literature review
.
Infez Med
.
2020 Dec 1
;
28
:
611
5
.
45.
Vaidya
T
,
Nanivadekar
A
,
Patel
R
.
Imaging spectrum of abdominal manifestations of COVID-19
.
World J Radiol
.
2021 Jun 28
;
13
(
6
):
157
70
. .
46.
Ghalib
N
,
Pophali
P
,
Chamorro-Pareja
N
,
Jayarangaiah
A
,
Kumar
A
.
Incidental asymptomatic splenic infarct in a COVID-19 patient
.
Cureus
.
2021 Feb 1
;
13
(
2
):
e13065
. .
47.
de Roquetaillade
C
,
Chousterman
BG
,
Tomasoni
D
,
Zeitouni
M
,
Houdart
E
,
Guedon
A
,
Unusual arterial thrombotic events in Covid-19 patients
.
Int J Cardiol
.
2021 Jan 15
;
323
:
281
4
.
48.
Tsaras
G
,
Owusu-Ansah
A
,
Boateng
FO
,
Amoateng-Adjepong
Y
.
Complications associated with sickle cell trait: a brief narrative review
.
Am J Med
.
2009 Jun
;
122
:
507
12
. .
49.
Yasmin
F
,
Najeeb
H
,
Naeem
A
,
Dapke
K
,
Phadke
R
,
Asghar
MS
,
COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management
.
Diseases
.
2021 Sep 22
;
9
(
4
):
65
.
50.
Singh
AK
,
Singh
R
,
Joshi
SR
,
Misra
A
.
Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India
.
Diabetes Metab Syndr
.
2021 Jul-Aug
;
15
(
4
):
102146
. .
51.
Maini
A
,
Tomar
G
,
Khanna
D
,
Kini
Y
,
Mehta
H
,
Bhagyasree
V
.
Sino-orbital mucormycosis in a COVID-19 patient: a case report
.
Int J Surg Case Rep
.
2021 May 4
;
82
:
105957
. .
52.
Dimopoulos
G
,
Almyroudi
MP
,
Myrianthefs
P
,
Rello
J
.
COVID-19-associated pulmonary aspergillosis (CAPA)
.
J Intensive Med
.
2021 Aug
;
1
(
2
):
71
80
.
53.
Ufuk
F
,
Bulgurcu
E
,
Sari
T
.
COVID-19-associated pancytopenia and typhlitis
.
Am J Emerg Med
.
2021 Jan 4
;
45
:
685.e1
e3
.
54.
Eifer
M
,
Eshet
Y
.
Imaging of COVID-19 vaccination at FDG PET/CT
.
Radiology
.
2021 May
;
299
(
2
):
E248
. .
55.
Shirone
N
,
Shinkai
T
,
Yamane
T
,
Uto
F
,
Yoshimura
H
,
Tamai
H
,
Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination
.
Ann Nucl Med
.
2012 Apr
;
26
:
248
52
.
56.
Burger
IA
,
Husmann
L
,
Hany
TF
,
Schmid
DT
,
Schaefer
NG
.
Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine
.
Clin Nucl Med
.
2011 Oct
;
36
:
848
53
. .
57.
Thomassen
A
,
Lerberg Nielsen
A
,
Gerke
O
,
Johansen
A
,
Petersen
H
.
Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination
.
Eur J Nucl Med Mol Imaging
.
2011 May
;
38
:
894
8
. .
58.
Bernstine
H
,
Priss
M
,
Anati
T
,
Turko
O
,
Gorenberg
M
,
Steinmetz
AP
,
Axillary lymph nodes hypermetabolism after BNT162b2 mRNA COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a Cohort Study
.
Clin Nucl Med
.
2021 May 1
;
46
:
396
401
.
59.
Cohen
D
,
Krauthammer
SH
,
Wolf
I
,
Even-Sapir
E
.
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation
.
Eur J Nucl Med Mol Imaging
.
2021 Jun
;
48
(
6
):
1854
63
. .
60.
Eifer
M
,
Tau
N
,
Alhoubani
Y
,
Kanana
N
,
Domachevsky
L
,
Shams
J
,
Covid-19 mRNA vaccination: age and immune status and its association with axillary lymph node PET/CT uptake
.
J Nucl Med
.
2022 Jan
;
63
(
1
):
134
9
.
61.
Orevi
M
,
Chicheportiche
A
,
Ben-Haim
S
.
Lessons learned from post-COVID-19 vaccination PET/CT studies
.
J Nucl Med
.
2021 Jul 22
:
jnumed
. Epub ahead of print.
62.
Eshet
Y
,
Tau
N
,
Alhoubani
Y
,
Kanana
N
,
Domachevsky
L
,
Eifer
M
.
Prevalence of increased FDG PET/CT axillary lymph node uptake beyond 6 weeks after mRNA COVID-19 vaccination
.
Radiology
.
2021 Sep
;
300
(
3
):
E345
7
. .
63.
Klok
FA
,
Pai
M
,
Huisman
MV
,
Makris
M
.
Vaccine-induced immune thrombotic thrombocytopenia
.
Lancet Haematol
.
2022
;
9
(
1
):
E78
80
.
64.
Perry
RJ
,
Tamborska
A
,
Singh
B
,
Craven
B
,
Marigold
R
,
Arthur-Farraj
P
,
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
.
Lancet
.
2021 Sep 25
;
398
:
1147
56
.
65.
Greinacher
A
,
Selleng
K
,
Palankar
R
,
Wesche
J
,
Handtke
S
,
Wolff
M
,
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
.
Blood
.
2021 Dec 2
;
138
(
22
):
2256
68
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.